BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7472824)

  • 1. Final height after long-term growth hormone treatment in Turner syndrome. European Study Group.
    Van den Broeck J; Massa GG; Attanasio A; Matranga A; Chaussain JL; Price DA; Aarskog D; Wit JM
    J Pediatr; 1995 Nov; 127(5):729-35. PubMed ID: 7472824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant growth hormone in children and adolescents with Turner syndrome.
    Cave CB; Bryant J; Milne R
    Cochrane Database Syst Rev; 2003; (3):CD003887. PubMed ID: 12917993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
    van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final height in Turner syndrome patients treated with growth hormone.
    Pasquino AM; Passeri F; Municchi G; Segni M; Pucarelli I; Larizza D; Bossi G; Severi F; Galasso C
    Horm Res; 1996; 46(6):269-72. PubMed ID: 8982737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growth pattern and final height of girls with Turner syndrome with and without human growth hormone treatment.
    Dacou-Voutetakis C; Karavanaki-Karanassiou K; Petrou V; Georgopoulos N; Maniati-Christidi M; Mavrou A
    Pediatrics; 1998 Apr; 101(4 Pt 1):663-8. PubMed ID: 9521953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height.
    Massa G; Heinrichs C; Verlinde S; Thomas M; Bourguignon JP; Craen M; François I; Du Caju M; Maes M; De Schepper J;
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4168-74. PubMed ID: 12970282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
    van Teunenbroek A; de Muinck Keizer-Schrama S; Stijnen T; Waelkens J; Wit JM; Vulsma T; Gerver WJ; Reeser H; Delemarre-van de Waal H; Jansen M; Drop S
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):451-9. PubMed ID: 9196608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
    Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
    J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prediction of final height in girls with Turner syndrome treated with growth hormone].
    Morin A; Guimarey L; Santucci Z; Apezteguia M
    Medicina (B Aires); 2000; 60(5 Pt 1):551-4. PubMed ID: 11188890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of long-term growth hormone treatment in Turner's syndrome. European Study Group.
    Van den Broeck J; Van Teunenbroek A; Hokken-Koelega A; Wit JM
    J Pediatr Endocrinol Metab; 1999; 12(5):673-6. PubMed ID: 10703540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial.
    Rosenfeld RG; Hintz RL; Johanson AJ; Brasel JA; Burstein S; Chernausek SD; Clabots T; Frane J; Gotlin RW; Kuntze J
    J Pediatr; 1986 Dec; 109(6):936-43. PubMed ID: 3537249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult height in sixty girls with Turner syndrome treated with growth hormone matched with an untreated group.
    Pasquino AM; Pucarelli I; Segni M; Tarani L; Calcaterra V; Larizza D
    J Endocrinol Invest; 2005 Apr; 28(4):350-6. PubMed ID: 15966509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final Adult Height after Growth Hormone Treatment in Patients with Turner Syndrome.
    Ahn JM; Suh JH; Kwon AR; Chae HW; Kim HS
    Horm Res Paediatr; 2019; 91(6):373-379. PubMed ID: 31480041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
    Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; Hokken-Koelega AC; Waelkens JJ; Massa GG; Vulsma T; Gerver WJ; Reeser HM; Delemarre-van de Waal HE; Jansen M; Drop SL
    Arch Dis Child; 1999 Jan; 80(1):36-41. PubMed ID: 10325756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with growth hormone therapy in Turner syndrome in a single centre: low total height gain, no further gains after puberty onset and unchanged body proportions.
    Schweizer R; Ranke MB; Binder G; Herdach F; Zapadlo M; Grauer ML; Schwarze CP; Wollmann HA
    Horm Res; 2000; 53(5):228-38. PubMed ID: 11150884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
    Quigley CA; Crowe BJ; Anglin DG; Chipman JJ
    J Clin Endocrinol Metab; 2002 May; 87(5):2033-41. PubMed ID: 11994337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group.
    Chernausek SD; Attie KM; Cara JF; Rosenfeld RG; Frane J
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2439-45. PubMed ID: 10902791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis.
    Johnston DI; Betts P; Dunger D; Barnes N; Swift PG; Buckler JM; Butler GE
    Arch Dis Child; 2001 Jan; 84(1):76-81. PubMed ID: 11124794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome.
    Reiter EO; Blethen SL; Baptista J; Price L
    J Clin Endocrinol Metab; 2001 May; 86(5):1936-41. PubMed ID: 11344188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.